Phytomedicine : international journal of phytotherapy and phytopharmacology

Sarsasapogenin may help treat bone loss from estrogen deficiency by boosting new blood vessel and bone formation through the GPX4/SLIT3/ROBO1 pathway

Updated

Abstract

Sarsasapogenin (SAR) improved osteogenesis and angiogenesis coupling in estrogen deficiency-induced osteoporosis in mice after 12 weeks of treatment.

  • SAR treatment enhanced cell viability and osteogenic differentiation in bone marrow stem cells.
  • Increased production of slit guidance ligand 3 (SLIT3) was observed in treated cells, which stimulated angiogenesis in human endothelial cells.
  • The coupling of osteogenesis and angiogenesis was promoted through the upregulation of the BMSCs-SLIT3/HUVECs-ROBO1 signaling axis.
  • Activation of the protein GPX4 was linked to SAR's effects on this coupling.
  • SAR directly interacted with GPX4, enhancing its stability and influencing SLIT3 production.
  • In GPX4-knockout mice, SAR did not elevate SLIT3 or indicators of osteogenesis or angiogenesis.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest There are no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free